[Cost Evaluation of First-Year Treatment for Locally Advanced or Metastatic Urothelial Carcinoma with Chemotherapy Plus Avelumab vs Chemotherapy Plus Best Supportive Care: A Cost o... by Daniela Paola Roggeri, Alessandro Roggeri, Anna Maria Provenzano, Francesca Ludovica Boffo, Roberto Iacovelli

Subjects: Get full text

Brain metastasis in a patient with metastatic urothelial carcinoma after 7 years of avelumab maintenance therapy: A case report by Kristoffer Ambeck Aagaard, Halldór Bjarki Einarsson, Sonja Höhle Hjulskov, Maria Teresa Figueroa Simonsen, Andreas Carus

Subjects: “…Avelumab…”
Get full text

Complete response after avelumab maintenance therapy: successful management of metastatic urothelial carcinoma by Rita Pinho, Maria João Oura, Francisco Botelho, Inês Nogueira Costa, Miguel Barbosa

Subjects: “…avelumab…”
Get full text

Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma by Zengguang Liu, Xiaofeng Cong, Chen Chen, Jiaxin Yin, Ziling Liu

Subjects: Get full text

Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real‐World, Ambispective RAVE‐Bladder Study by Ilya Tsimafeyeu, Yana Gridneva, Alexander Sultanbaev, Yulia Anzhiganova, Mark Gluzman, Anastasia Mochalova, Alexey Shkurat, Edgar Israelyan, Elvira Parsadanova, Yulia Murzina, Aleksei Ivanov, Alexey Kalpinskiy, Olesia Stativko, Vladislav Petkau, Elena Karabina, Artyom Kеln, Natalya Tovbik, Sufia Safina, Maria Turganova, Evgeny Kopyltsov, Varvara Bragina, Olga Novikova, Andrei Lebedinets, Vladislav Vodolazskiy, Alexey Rumyantsev, Ruslan Zukov, Ilya Pokataev, Rashida Orlova, Maria Volkova

Subjects: “…avelumab…”
Get full text

Avelumab in First Line Maintenance in Advanced Urothelial Carcinoma (aUC) in Elderly Patients: Efficacy, Tolerability, and Quality of Life in Real Life Setting by Rossella De Luca, Pasquale Vitale, Alessio Pepe, Roberta Spedaliere, Alchiede Simonato, Raffaele Addeo, Giuseppe Cicero

Subjects: “…Avelumab…”
Get full text

Evolving treatment patterns and outcomes among patients with metastatic urothelial carcinoma post-avelumab maintenance approval: insights from The US Oncology Network by H. Li, S. Sura, A. Babcock, L. Herms, J. Guo, P. Conkling, S. Franco, P. Singhal, R. Mamtani, M. Bupathi

Subjects: Get full text

READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma by L. Antonuzzo, M. Maruzzo, U. De Giorgi, D. Santini, R. Tambaro, S. Buti, F. Carrozza, F. Calabrò, G. Di Lorenzo, G. Fornarini, R. Iacovelli, D. Cullurà, C. Messina, L. Cerbone, G. Fazzi, F. Venturini, R. Colasanto, A. Necchi, S. Bracarda

Subjects: “…avelumab…”
Get full text

NRAS tumor mutations are associated with reduced odds of dermatologic adverse events in patients with metastatic melanoma receiving immune checkpoint inhibitors by Michael S. Chang, MD, Jordan T. Said, MD, Elliot H. Akama-Garren, PhD, Nicole Trepanowski, MD, Ai-Tram N. Bui, MD, Anita Giobbie-Hurder, MS, Nicole R. LeBoeuf, MD, MPH, Rebecca I. Hartman, MD, MPH

Subjects: Get full text

MODERN POSSIBILITIES OF THERAPY WITH INHIBITORS OF CONTROL POINTS IN METASTATIC UROTHELIAL CANCER by R. A. Gafanov, S. V. Garmash, I. B. Kravtsov, S. V. Fastovets

Subjects: Get full text

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review) by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, O. N. Lipatov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova

Subjects: Get full text

PD-L1 as a Potential Target in Cancer Therapy (Review) by N. N. Andrusova, M. A. Kolganova, A. V. Aleshina, I. E. Shohin

Subjects: Get full text

Case Report: The immune architecture of immunotherapy-induced cutaneous sarcoidosis resembles peritumoral inflammation by Catherine J. Wang, Jennifer Strong, Margaret E. Gatti-Mays, Wiem Lassoued, Sam Sater, Julius Strauss, Jason M. Redman, Jason M. Redman, Jeffrey Schlom, James L. Gulley, Isaac Brownell, Isaac Brownell

Subjects: Get full text

Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/aveluma... by C. D’Alterio, G. Rea, M. Napolitano, E. Coppola, A. Spina, D. Russo, R. Azzaro, C. Mignogna, G. Scognamiglio, D. Califano, L. Arenare, C. Schettino, C. Pisano, S. C. Cecere, M. Di Napoli, A. Passarelli, F. Perrone, S. Pignata, S. Scala

Subjects: Get full text

Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-... by Sneha Sura, Manojkumar Bupathi, Valerie Morris, Paul Conkling, Karen Todoroff, Abhijeet Bhanegaonkar, Chiemeka Ike

Subjects: “…avelumab…”
Get full text